KRYS 241220 210.00C (KRYS241220C210000) Stock Options, News & Quotes

US OptionsDetailed Quotes

KRYS241220C210000

Watchlist

4.00
+2.98+292.16%

15min DelayClose Nov 22 16:00 ET

4.00High2.10Low

Intraday

5D
Daily

News

Some Confidence Is Lacking In Krystal Biotech, Inc.'s (NASDAQ:KRYS) P/S
Simply Wall StNov 7 12:56 ET
Krystal Biotech, Inc. (NASDAQ:KRYS) Just Released Its Third-Quarter Earnings: Here's What Analysts Think
Yahoo FinanceNov 7 08:04 ET
Unusual Options Activity: C, DAL and Others Attract Market Bets, C V/OI Ratio Reaches 519.3
Moomoo NewsNov 6 11:30 ET
Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference
GlobeNewswireNov 6 07:00 ET
Krystal Q3 Earnings and Sales Top Estimates, Vyjuvek Gains Traction
Zacks Nov 5 13:00 ET
Krystal Biotech Is Maintained at Neutral by Citigroup
Dow JonesNov 5 09:59 ET · Ratings

Comments

Bull X Bear

Oct 11 11:12

US Market Movers

Banks: $JPMorgan (JPM.US)$ $Wells Fargo & Co (WFC.US)$ $Bank of America (BAC.US)$
Capital Markets: $UP Fintech (TIGR.US)$ $Cipher Mining (CIFR.US)$ $CleanSpark (CLSK.US)$
Biotechnology: $Genfit (GNFT.US)$ $Spyre Therapeutics (SYRE.US)$ $Krystal Biotech (KRYS.US)$
Software: $Verb Technology (VERB.US)$ $SurgePays (SURG.US)$ $Uber Technologies (UBER.US)$
Asset Management: $Westwood Holdings (WHG.US)$ $BrightSphere Investment (BSIG.US)$ $Blackrock (BLK.US)$
Specialty Industrial Machinery: $JE Cleantech Holdings Limited (JCSE.US)$ $Taylor Devices (TAYD.US)$ $CSW Industrials (CSWI.US)$
...

lSlippyl

Jul 26 03:41

$Krystal Biotech (KRYS.US)$ $1,000

lSlippyl

Jul 14 21:30

$Krystal Biotech (KRYS.US)$ 🤣🤣🤣🤣🤣

Moomoo AI

Feb 25 06:39

The strong revenue growth is mirrored in the share price gain. Despite the strong run, top performers like Krystal Biotech can continue winning for decades. The stock's recent performance improvement may suggest real business momentum.

Investing in Krystal Biotech (NASDAQ:KRYS) Five Years Ago Would Have Delivered You a 389% Gain

Moomoo AI

Jan 29 04:54

High insider ownership at Krystal Biotech implies management's alignment with shareholders. Yet, no insider transactions in the last three months and significant share selling over the past year are concerning.

Krystal Biotech Insiders Sold US$16m Of Shares Suggesting Hesitancy